The Food and Drug Administration approved an AstraZeneca-made treatment for advanced breast cancer. The agency on Friday said it granted accelerated approval for AstraZeneca's Etcamah drug, known ...

Bloom and Sandisk were among the top gainers this week, while software stocks lagged.

Homeowners are worried about what data centers will do to their home values Research from outside the tech industry suggests that the link between data centers and home values is weak. But homeowners ...

If you're 55 years old and you put $32,500 into your 401(k) this year, your statement will tell you that you maxed out. You didn't. The actual ceiling on that account is $80,000. Most people never ...

August’s payroll strength was broad-based. Jeff Schulze, chief investment strategist at Franklin Templeton Institute, called ...

Off 11.59% from its record high of $5.1354 hit Thursday, April 28, 2022 --Year-to-date it is up $2.4196 or 114.10% All prices are calculated based on the settlement price of the current front month ...

Front Month Nymex RBOB Gasoline for Oct. delivery gained 16.44 cents per gallon, or 5.39% to $3.2146 this week --Largest one week percentage gain since the week ending Aug. 14, 2026 --Largest four ...

AARD Stockholders Have Rights – If You Lost Money Investing in Aardvark Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses ...

Zscaler ZS reported fourth-quarter earnings that included sales of $898 million, up 25%, and adjusted operating margins of 24 ...

Three big credit firms are "overcharging Americans," according to Bill Pulte, the head of the Federal Housing Finance Agency. Week Ahead for FX, Bonds: U.S. Inflation Data in Focus; ECB Expected to ...

EQT has agreed to buy a majority stake in insurance broker McGill and Partners for $2 billion, the Swedish investment group said. The company's shares declined in after-hours trading after the drug ...

A heart disease drug made by Ionis Pharmaceuticals and Novartis didn't meet its primary endpoint in a Phase 3 trial. Ionis shares slid 9.5% to $52.60 in after-hours trading on Friday, while Novartis ...